FOCL (FOCL) Stock Price & Analysis
FOCL (FOCL) fell 0.48% to USD 4.15 as of September 8, 2026 at 09:06 UTC, according to Nexqual real-time market data.
FOCL last closed at USD 4.15; the session ranged USD 4.15–4.24 on volume of 103,139 shares. Market capitalization is —, with a 52-week range of USD 1.75–6.4 (NGM). Source: Nexqual, September 8, 2026 at 09:06 UTC.
Key Statistics (as of September 8, 2026 at 09:06 UTC)
| Price | USD 4.15 |
|---|---|
| Change | ▼ 0.48% (down) |
| Previous Close | USD 4.15 |
| Open | USD 4.15 |
| Day Range | USD 4.15 – 4.24 |
| 52-Week Range | USD 1.75 – 6.4 |
| Volume | 103,139 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (FOCL)
Nexqual's technical model rates FOCL "STRONG SELL" based on 0 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 09:06 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 33.29 (neutral) |
| vs SMA50 | Below (USD 5.22) |
| MACD | -0.33 (negative) |
Leadership (FOCL)
FOCL is led by Ryan Rhodes (age 63), CEO & Director, per Nexqual as of September 8, 2026 at 09:06 UTC.
| CEO & Director | Ryan Rhodes (age 63) |
|---|---|
| Chief Financial Officer | Kenneth Mobeck (age 54) |
| Executive Vice President of Marketing & Product Management | Steven Annen (age 61) |
| Chief Operating Officer | Carre Emmanuel |
| President of EDAP TMS France | Frederic Pech (age 56) |
Major Backers & Investors (FOCL)
Notable institutional backers of FOCL include Soleus Capital Management, L.P., Morgan Stanley, Flax Pond Capital, LLC, according to Nexqual as of September 8, 2026 at 09:06 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Soleus Capital Management, L.P. | 19.48% |
| Morgan Stanley | 8.89% |
| Flax Pond Capital, LLC | 4.07% |
| Rock Springs Capital Management, LP | 3.69% |
| Bruce & Co, Inc. | 1.17% |
| Bruce Fund, Inc.-BRUCE FUND | 1.11% |
| Parkman Healthcare Partners LLC | 0.41% |
| Essex Investment Management Co LLC | 0.39% |
Source: Nexqual, September 8, 2026 at 09:06 UTC.
From FOCL's Latest SEC 10-K Filing (filed 2026-03-25)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| IRIX | IRIDEX Corporation | USD 0.7 | ▼ 2.78% |
| ELTK | Eltek Ltd. | USD 8.24 | ▲ 8.42% |
| ICCC | ImmuCell Corporation | USD 9.9 | ▼ 1% |
| BGMSP | Bio Green Med Solution Inc. | USD 2.81 | ▲ 0% |
| SSKN | Strata Skin Sciences, Inc. | USD 0 | ▼ 100% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 09:06 UTC. This page is informational and not investment advice.